Experiment 1177773
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | BOUTIN,C: IRISSON,M: GUERIN,JC: ROEGEL,E: PARAMELLE,B: BRAMBILLA,C: JEANNIN,L: DABOUIS,G: LE CAER,H: VIALLAT,JR:. (1987). PHASE II TRIAL OF VINDESINE IN MALIGNANT PLEURAL MESOTHELIOMA.. 71(2) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN THIS PHASE II TRIAL 21 PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA WERE GIVEN 2 MG/SQ.M./DAY FOR 2 CONSECUTIVE DAYS EVERY 2 WEEKS. IF MYELOTOXICITY WAS PRESENT, DOSES WERE DECREASED BY 50%. THERE WERE NO OBJECTIVE RESPONSES. THERE WERE 8 PATIENTS WITH STABLE DISEASE AND 13 WITH PROGRESSIVE DISEASE. TOXICITY WAS CONSIDERED MILD, THOUGH TREATMENT WAS STOPPED IN ONE PATIENT DUE TO PERIPHERAL NEUROTOXICITY AFTER 2 COURSES. |
| Dose amount | 2.0 MG |
| Number | 1 |
| Qualitative result | EQUIVOCAL |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |